ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,555Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 537

$1.23M Total Retail Price of All Prescriptions

Rank: 6 out of 537

775 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 775 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,359 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$98 was the average price of a prescription from this provider, compared to $126 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 693 418 1 1
METOPROLOL SUCCINATE 619 416 2 20
LISINOPRIL 578 357 3 3
RENVELA 533 186 4 4
FUROSEMIDE 474 359 5 2
CALCITRIOL 421 325 6 13
CALCIUM ACETATE 417 149 10 7 6
LOSARTAN POTASSIUM 407 261 8 15
SIMVASTATIN 328 232 9 12
CARVEDILOL 267 161 10 7
GLIPIZIDE 253 180 11 42
FAMOTIDINE 234 160 12 30
METOPROLOL TARTRATE 210 151 13 9
LEVOTHYROXINE SODIUM 210 161 13 18
TORSEMIDE 193 162 15 35
ALLOPURINOL 182 148 16 14
CLONIDINE HCL 163 74 17 10
ATORVASTATIN CALCIUM 162 98 18 26
GABAPENTIN 160 109 19 25
CLOPIDOGREL 147 77 20 52
OMEPRAZOLE 145 104 21 19
JANUVIA 141 128 22 57
CILOSTAZOL 139 134 23 136
HYDROCHLOROTHIAZIDE 134 114 24 32
POTASSIUM CHLORIDE 133 124 25 29
TRAMADOL HCL 127 84 26 31
NEXIUM 126 67 27 23
PANTOPRAZOLE SODIUM 124 97 28 33
TAMSULOSIN HCL 122 117 29 43
SERTRALINE HCL 116 68 30 53
ISOSORBIDE MONONITRATE ER 114 82 31 54
PRAVASTATIN SODIUM 105 68 32 28
SENSIPAR 101 60 33 5
LACTULOSE 100 76 34 69
ATENOLOL 92 66 35 51
LEVOFLOXACIN 91 56 36 60
PLAVIX 90 37 37 64
METOCLOPRAMIDE HCL 89 46 38 62
LANTUS 86 54 39 44
DIOVAN 84 68 40 24
NOVOLIN 70-30 83 34 41 81
AZITHROMYCIN 80 41 42 58
CRESTOR 75 62 43 49
INSULIN SYRINGE 73 38 44 47
HYDROCODONE-ACETAMINOPHEN 68 33 S3 45 8
HYDRALAZINE HCL 68 28 45 11
PROSOL 63 33 47 17
PROCRIT 62 50 48 79
MEGESTROL ACETATE 60 53 R 49 98
GLIPIZIDE ER 59 48 50 74
HECTOROL 55 38 51 85
METFORMIN HCL 55 33 51 46
WARFARIN SODIUM 55 35 51 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 54 54 146
PREDNISONE 51 28 55 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.